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Abstract
In response to numerous signals, latent herpesvirus genomes abruptly switch their developmental program, aborting stable
host–cell colonization in favor of productive viral replication that ultimately destroys the cell. To achieve a rapid gene
expression transition, newly minted capped, polyadenylated viral mRNAs must engage and reprogram the cellular
translational apparatus. While transcriptional responses of viral genomes undergoing lytic reactivation have been amply
documented, roles for cellular translational control pathways in enabling the latent-lytic switch have not been described.
Using PEL-derived B-cells naturally infected with KSHV as a model, we define efficient reactivation conditions and
demonstrate that reactivation substantially changes the protein synthesis profile. New polypeptide synthesis correlates with
4E-BP1 translational repressor inactivation, nuclear PABP accumulation, eIF4F assembly, and phosphorylation of the cap-
binding protein eIF4E by Mnk1. Significantly, inhibiting Mnk1 reduces accumulation of the critical viral transactivator RTA
through a post-transcriptional mechanism, limiting downstream lytic protein production, and impairs reactivation efficiency.
Thus, herpesvirus reactivation from latency activates the host cap-dependent translation machinery, illustrating the
importance of translational regulation in implementing new developmental instructions that drastically alter cell fate.
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Introduction
Regulation of gene expression at the level of mRNA translation
is important for the control of numerous biological processes
including cell growth, differentiation, development and the
response to environmental stress [1,2]. Unlike prokaryotes, the
vast majority of eukaryotic mRNAs are unable to recognize
ribosomes directly and rely instead on an intricate set of translation
initiation factors that assemble a specialized multisubunit complex
onto the mRNA 59 terminus to recruit the 40S ribosome subunit.
For 7-methyl GTP capped mRNAs, this involves eIF4F, a
tripartite complex that includes a cap-binding subunit (eIF4E)
and an RNA helicase (eIF4A) tethered to eIF4G, a large molecular
platform that contacts the eIF3-bound 40S subunit. In addition,
eIF4G associates with other translational control proteins such as
the eIF4E kinase Mnk1 and the poly(A)-binding protein (PABP),
which directly binds the mRNA 39 end and indirectly contacts the
59 end through eIF4G. Moreover, the responsiveness of individual
constituents of this complex to a wide spectrum of cellular signals
allows the translational machinery to respond rapidly to diverse
physiological effectors [3]. The 4E-BP translational repressor
family, for example, sequesters eIF4E and prevents binding to
eIF4G, limiting ribosome recruitment. Similarly, the ERK and
p38-responsive eIF4G-associated kinase Mnk1 modulates eIF4E
phosphorylation, which in specific instances has been associated
with increased translation rates [4–7]. Thus, regulated translation
initiation factor complex assembly and modification is poised to
potentiate important developmental decisions by controlling global
and specific mRNA translation.
Viruses provide attractive models to study simple developmental
decisions. In prokaryotes, much has been learned using bacterio-
phage l toinvestigate how thelysis-lysogenydecision ismade [8].In
eukaryotes, latent herpesviruses exist in one of two developmental
states within their hosts and must resolve an analogous question of
whether to remain latent or initiate productive viral growth.
Different herpesviruses permanently colonize distinct specialized
host cell-types. Those that establish residency in dividing cell
populations, exemplified bymembersofthec-herpesvirus subfamily
that includes Kaposi’s sarcoma associated herpesvirus (KSHV/
HHV8), express a limited subset of viral genes that stimulate cell
proliferation, allow for viral minichromosome replication and
segregation, and evade antiviral defenses [9]. In response to poorly
understood environmental cues, these viruses can switch to a
developmental program that results in productive replication. This
alternate pathway involves activating a temporally coordinated
cascade of viral lytic gene expression, which in turn results in
massive viral DNA amplification, progeny virus production, and
ultimately host cell destruction[10,11]. To effectively switchits gene
expression program, all herpesviruses produce a new population of
viral mRNAs transcribed by the cellular RNA polymerase II, which
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[12–16], and these must successfully engage and reprogramthe host
cell translational apparatus. This is a critical component of the
developmental switch because viruses are absolutely dependent
upon the translational machinery resident in their hosts [17].
Manipulating host translation initiation factors to ensure that
nascent viral mRNAs successfully recruit ribosomes will therefore
determine the overall level and efficacy with which the newly
transcribeddevelopmental instructionsareexecuted.Whilewehave
a general understanding of how the viral transcriptome is altered for
many viruses, a role for translational control in the developmental
switch from a latent to a productively replicating state has not been
described.
One of the earliest events in the genetic switch that initiates
productive KSHV replication is the accumulation of RTA, a
transcription factor encoded by ORF50 [18–20]. By recruitment to
promoter elements in the viral genome, RTA triggers a complex
program of viral mRNA synthesis resulting in replication and
assembly of infectious viral particles. Here we establish efficient
conditions for KSHV reactivation that reveal major alterations in the
protein synthesis profile of a naturally infected B-cell line. These
changes are accompanied by inactivation of the 4E-BP1 translational
repressor, eIF4F assembly, and eIF4E phosphorylation. Moreover,
inhibiting the eIF4E kinase Mnk1 impaired viral entry into the lytic
cycle and reduced the overall abundance of the master viral activator
RTA via a post-transcriptional mechanism. Together, these results
establish a role for remodeling and modifying cellular translation
initiation factor complexes in orchestrating global changes in protein
synthesis during reactivation of latent viruses, and highlight the
importance of translational as well as transcriptional control in
executing a simple developmental decision.
Results
Efficient reactivation of KSHV in response to combined
stimuli in engineered cell lines
Much of our knowledge of the developmental switch that
maintains latency or promotes productive viral replication has
been garnered from studies of primary effusion lymphoma (PEL)-
derived B-cell lines (such as BCBL1 cells) latently-infected with
KSHV. While KSHV lytic replication can be induced by ectopic
expression of the viral transactivator RTA or treatment with
chemicals such as phorbol esters (TPA) or sodium butyrate, the
low efficiency with which reactivation is induced severely limits the
system’s utility because only a small number of cells undergo lytic
replication at any given moment. In hopes of obtaining greater
levels of reactivation from latency, we turned to an inducible
BCBL1-derived cell line (TREx BCBL1-RTA) developed by Jung
and colleagues that expresses epitope-tagged RTA under the
control of a tetracycline-inducible promoter [21]. One limitation
of this system is that it cannot address the contribution, if any, of
early nuclear events in RTA mRNA biogenesis that precede
cytoplasmic mRNA accumulation such as transcription template
effects, differential mRNA splicing, and nuclear export. Through a
well-described positive feedback loop, expression of RTA from the
cDNA incorporated into the cellular genome also induces the viral
genomic ORF50 locus and therefore a mixture of ectopic and
natural RTA transcripts are produced in the reactivating cells
[19,21,22].
To evaluate reactivation in TREx BCBL1-RTA cells in
response to TPA, or the tetracycline analog doxycycline (DOX),
we scored ORF59 delayed-early lytic gene product accumulation
by immunofluorescence. The overwhelming majority of the initial
starting cultures were latently infected with KSHV, as all the cells
were positive for LANA, a KSHV latent infection marker (not
shown), and less than 5% exhibited staining for ORF59 (Fig. 1A).
This basal ORF59 staining reflects the low spontaneous lytic
reactivation routinely seen in these cultures. While ORF59
accumulated between 24–48 h post-induction with TPA or
DOX alone, this was limited to only 15–20% of the cells
(Fig. 1A, B) and was similar to the level observed in the parental
TREx BCBL-1 line treated with TPA alone. Combining both
stimuli (TPA+DOX) resulted in a synergistic response where more
than 50% of the TREx BCBL1-RTA population was ORF59
positive at 24 h post-induction, and this approached 80% of the
cells after 48 h (Fig. 1 A, B). Inducible reactivation of this
magnitude in a naturally infected, KSHV-positive PEL B-cell line
has not been reported previously. The accumulation of other viral
proteins, notably the critical transactivator RTA and the late
glycoprotein K8.1 paralleled the ORF59 increase (Fig. 1C, lanes
2,5). Significantly, whereas K8.1 levels after 48 h TPA+DOX
treatment were robust, the protein was not detected in cultures
treated only with TPA or DOX individually (Fig. 1C, lanes 3–4,
6–7). Expression of the K8.1 late gene is dependent upon prior
DNA synthesis and is thus a ‘‘true-late’’ lytic marker that reflects
the progression of the viral lytic cycle well beyond the point of
ORF59 expression. Furthermore, accumulation of slower migrat-
ing, glycosylated forms of K8.1 from 48 h onward (e.g., see panel
B of figure four), indicative of their maturation as they traffic
through the cellular secretory pathway, is consistent with
progression of the lytic program into later phases of the productive
growth cycle. Lastly, infectious virus production was confirmed by
applying cell-free lysates prepared from TREx-BCBL1-RTA cells
either treated with DMSO or induced with TPA+DOX onto a
293 PAN-luc reporter cell line which expresses the firefly luciferase
gene under the control of the RTA-responsive PAN promoter
[23]. Activation of an RTA-responsive gene in a reporter cell line
following application of cell-free supernatants is a powerful
indicator of infectious virus production [23,24]. Luciferase activity
was exclusively detected in lysates prepared from TPA+DOX-
treated cultures, establishing that only lysates from TPA+DOX
treated cultures were capable of activating an RTA-responsive
Author Summary
Kaposi’s sarcoma-associated herpesvirus (KSHV) is an
important human pathogen and, like all herpesviruses,
establishes a state of permanent residency in the infected
host called latency. Major sites of KSHV latency are cells of
the immune system and cells lining blood vessels. In
individuals with weakened immunity, inappropriate growth
of these cells driven by the resident virus can give rise to
primary effusion lymphoma and Kaposi’s sarcoma, respec-
tively. These life-threatening cancers are most common in
patients with HIV/AIDS and have become a major source of
mortality in parts of sub-Saharan Africa. Under appropriate
stimuli, herpesviruses change their relationship with the
host cell and begin to manufacture proteins required to
assemble new infectious virus particles that can be released
and spread. To achieve this, the virus hijacks key processes
within the cell and conscripts them into producing viral
proteins. In this study, we describe for the first time how
KSHV carefully manipulates the host protein synthesis
machinery duringthe switch from latency to this specialized
infectious virus production mode. Our results show that
although overall protein synthesis is diminished, key
components of the host’s protein manufacturing machinery
are actually stimulated, presumably to accelerate viral
protein production.
Translational Control during KSHV Reactivation
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mediated by infectious KSHV particles in the cell-free lysate
(Fig. S1). Thus, the reactivation conditions used throughout this
study do result in infectious virus production, which correlates well
with ORF59 and K8.1 accumulation, our two other independent
experimental markers for reactivation. Lytic reactivation in TREx
BCBL1-RTA cultures treated individually with DOX or TPA was
not simply delayed compared to treatment with both drugs
because the number of ORF59-positive cells only increased
beyond the 20% mark after prolonged incubation and was
accompanied by massive cell death, hindering further analysis (not
shown). As a control, viral reactivation was significantly lower after
TPA+DOX treatment of the parental cell line TREx BCBL1,
which does not express ectopic RTA (not shown; Fig. 2B). Thus,
TREX BCBL1-RTA cultures treated with both TPA+DOX
induced a much larger fraction of cells to enter the productive
growth cycle as measured by early and late viral lytic gene
expression.
Reactivation from latency alters the protein synthesis
profile in naturally infected PEL-derived B-cells
Having established conditions where 80% of the latently-
infected cells in the population were routinely induced to enter the
KSHV lytic cycle, it was now possible to directly evaluate how
switching from latency to lytic replication altered the profile of
polypeptides produced in a naturally infected PEL-derived cell
line. To characterize cellular protein synthesis following KSHV
reactivation from latency in the PEL-derived B-cells, TREx
BCBL1 and TREx BCBL1-RTA cells were treated with a
combination of TPA+DOX for 24 or 48 h. After metabolic
labeling with
35S amino acids for 30 min., total protein was
isolated, fractionated by SDS-PAGE, and visualized by autoradi-
ography. By 24 h post-induction, a modest reduction in
35S-
incorporation into newly synthesized proteins was evident in
TREx BCBL1-RTA cells (Fig. 2A). While numerous bands were
reduced in intensity compared to the 0 h point, new polypeptide
species migrating at different positions relative to the molecular
weight standards were clearly visible (Fig. 2A). Some of these
proteins continued to be produced at a similar rate despite the
continued overall suppression of protein synthesis evident at 48 h
post-induction. The selective, sustained accumulation of these new
polypeptide species while global mRNA translation rates are
suppressed suggests that they represent de novo synthesis of viral
factors or cellular proteins produced in response to active infection
(Fig. 2A). Further investigation will be necessary to determine the
precise identity and nature of these proteins. The global
suppression of host protein synthesis triggered by lytic reactivation,
however, could involve accelerated mRNA decay, as shown for the
KSHV ORF37 (SOX) gene product in immortalized endothelial
cells [25]. Significantly, the relative abundance of a representative
set of cellular mRNAs (b-actin, GAPDH, IL-2, b-catenin)
measured by real-time PCR after 48 h of TPA+DOX treatment
was only modestly reduced between one to five-fold compared
with control, uninduced samples (Fig. 2C). Whilst these changes in
mRNA steady-state levels will most likely contribute to the
observed impairment of global mRNA translation upon KSHV
lytic reactivation, the comparatively modest extent to which
mRNA levels decline may not be sufficient to fully account for the
reduced translation observed in Fig. 3A. In contrast, protein
synthesis proceeded unaltered in the TPA+DOX-treated parental
TREx BCBL1 cells (Fig. 2A) or TREx BCBL1-RTA cells
individually treated with DOX alone (not shown). Finally, the
accumulation of specific viral proteins, including K8.1, was only
observed in TREx BCBL1-RTA cells, but not in the parental
TREx BCBL1 cells, in response to combined TPA+DOX
treatment (Fig. 2B). Together, these observations suggest that the
switch of KSHV from one developmental state (latency) to an
alternative state (lytic replication) is accompanied by a strong
suppression of host protein synthesis. This represents the first
demonstration that inducting lytic replication in a naturally
infected PEL-derived cell line suppresses overall protein synthesis.
Inactivation of the 4E-BP1 translational repressor during
reactivation from latency
Given the significant changes to global protein synthesis rates
following reactivation from latency, we investigated if modification
of the cellular cap-dependent translational machinery was
associated with and contributes to reactivation. To this end, we
first focused on 4E-BP1, a translational repressor that regulates the
availability of the cap-binding protein eIF4E [3]. In its hypopho-
sphorylated form, 4E-BP1 sequesters eIF4E and thereby prevents
eIF4G binding, eIF4F complex assembly, and 40S subunit
Figure 1. Efficient KSHV reactivation from naturally infected
PEL-derived TREx BCBL1-RTA cells. A. Immunofluorescence
analysis of KSHV lytic reactivation. PEL-derived TREx BCBL1-RTA cells
were treated with TPA, doxycycline (DOX) or TPA+DOX for 24 h or 48 h.
Fixed, permeabilized cells were then immunostained with antisera
specific for the KSHV delayed-early protein ORF59 (green signal), a
marker of KSHV lytic replication, and the DNA counterstained with
propidium iodide (red signal). The photographs show representative
fields of independent, triplicate experiments. B. The percentage of
ORF59-positive cells was quantified by counting at least 1000 cells from
the samples in A. Error bars: Standard deviations from independent,
triplicate experiments. C. Accumulation of KSHV lytic gene products in
TREx BCBL1-RTA cells induced to reactivate. Total protein isolated from
the samples described in A and B was fractionated by SDS-PAGE and
analyzed by immunoblotting usingt h ei n d i c a t e da n t i s e r a .T h e
arrowhead indicates the mobility of full-length RTA. Cellular RhoGDI
serves as a loading control.
doi:10.1371/journal.ppat.1000334.g001
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structure. 4E-BP1 phosphorylation by mTORC1 liberates eIF4E,
allowing it to bind eIF4G and assemble a functional eIF4F
complex, which in turn mediates 40S ribosome subunit recruit-
ment to the capped 59 mRNA terminus (Fig. 3A). To determine
how KSHV reactivation affects 4E-BP1 phosphorylation, total
protein isolated from TPA+DOX-treated TREx BCBL1-RTA
cells or the parental TREx BCBL1 line was fractionated by SDS-
PAGE in a 17.5% gel capable of resolving 4E-BP1 phosphorylated
isoforms and visualized by immunoblotting using anti-4E-BP1
antibodies. After 48 h of treatment, slower migrating bands
corresponding to hyperphosphorylated 4E-BP1 were observed
(Fig. 3B, compare lanes 2 and 4). Moreover, hyperphosphorylated
4E-BP1 accumulation was not detected in the TPA+DOX-treated
parental TREx BCBL1 cells, suggesting that 4E-BP1 hyperpho-
sphorylation is dependent on viral reactivation and not on the
pharmacological treatment of the cells per se. Rapamycin, an
inhibitor of the cellular kinase mTORC1, prevented hyperpho-
sphorylated 4E-BP1 accumulation demonstrating a requirement
for mTORC1 activity (Fig. 3B). mTORC1 stimulation could
result from viral and/or cellular effectors acting upstream of or
directly on mTORC1 components. The preponderance of
hypophosphorylated 4E-BP1 in TREx BCBL1 and uninduced
TREx BCBL1-RTA cells, irrespective of rapamycin treatment
indicates that basal mTORC1 activity in these latently infected,
actively dividing, transformed PEL cells is limited (Fig. 3B).
However, despite efficiently reducing 4E-BP1 phosphorylation,
preventing inactivation of the repressor 4E-BP1 with rapamycin
did not significantly change the fraction of TREx BCBL1-RTA
cells capable of supporting KSHV lytic reactivation, as determined
by ORF59 immunofluorescence and immunoblotting for RTA or
K8.1 (Fig. 3C). This suggests that the overall levels of the 4E-BP1
repressor may not be capable of sequestering enough eIF4E to
have a detectable effect in these transformed PEL cell lines.
Nevertheless, the induction of the viral lytic program is capable of
inactivating the 4E-BP1 translational repressor.
Reactivation from latency promotes eIF4F assembly
While inactivation of the repressor 4E-BP1 can modulate eIF4E
availability, its ability to regulate translation depends upon its
overall abundance. In addition, repressor inactivation is not always
accompanied by eIF4F assembly, which requires the association of
eIF4E with eIF4G [26]. To determine if KSHV reactivation can
influence eIF4F complex formation, eIF4E-associated proteins
present in non-ionic detergent lysates prepared from TPA+DOX-
treated TREx BCBL1 and TREx BCBL1-RTA cells were isolated
by batch chromatography on 7-M GTP sepharose. After washing,
bound polypeptides were fractionated by SDS-PAGE and
Figure 2. KSHV lytic reactivation changes the ongoing protein
synthesis profile in naturally infected, PEL-derived B-cells. A.
TREx BCBL1 and TREx BCBL1-RTA cells were treated with TPA+DOX and
metabolically labeled for 30 min with
35S amino acids at the indicated
times post-induction. Total protein was isolated, fractionated by SDS-
PAGE and the fixed, dried gel exposed to X-ray film. Asterisks (*)
indicate newly synthesized proteins detected only in TREx BCBL1-RTA
cells induced with TPA+DOX. Molecular weight standards appear in the
leftmost lane and their sizes (in KDa) are indicated in the margin. B.
Same as in A except the samples were analyzed by immunoblotting
using the indicated antisera. Cellular RhoGDI serves as a loading control.
C. Total RNA was isolated from TREx BCBL-1-RTA cells treated with
DMSO or induced with TPA+DOX for 48 h. Changes in the overall
relative abundance of the indicated representative cellular mRNAs in
uninduced (DMSO-treated) vs TPA+DOX-induced cells was measured by
real-time RT-PCR analysis.
doi:10.1371/journal.ppat.1000334.g002
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of eIF4G retained (by eIF4E) on the 7-M GTP matrix increased in
TREx BCBL1-RTA cells induced to reactivate with TPA+DOX,
whereas changes in the amount of the cap-binding protein eIF4E
or PABP in the bound fraction were not observed (Fig. 4A). No
differences in the amounts of eIF4E, eIF4G, or PABP bound to
eIF4E were detected in lysates prepared from TPA+DOX-treated
parental TREx BCBL1 cells (Fig. 4A). Taken together, this
demonstrates that KSHV lytic reactivation stimulates eIF4F
assembly by selectively recruiting eIF4G to cap-bound eIF4E.
The increased amount of eIF4G bound to eIF4E was not
accompanied by detectable changes in the overall steady state
levels of eIF4E, eIF4G, eIF4A, PABP, or 4E-BP1 in either input
samples or whole cell extracts (Fig. 4A, 4B). However, the basal
levels of these factors was much greater when equivalent numbers
of live, transformed PEL cells were compared with primary human
dermal fibroblasts despite their similar levels of RhoGDI and Actin
(Fig. 4C).
Since eIF4G and the translational repressor 4E-BP1 both bind
to the same site on eIF4E, it was surprising that the amount of 4E-
BP1 retained by eIF4E remained relatively constant despite a
significant increase in eIF4G- binding (Fig. 4A). Analysis of the
protein fraction prepared from TPA+DOX-induced TREx
BCBL1-RTA cells that was not retained on 7-M GTP Sepharose
revealed that it was more enriched in 4E-BP1 hyperphosphory-
lated isoforms than the input material (Fig. 4D). Conversely, 4E-
BP1 hyperphosphorylation was not detected in any samples
prepared from the parental TREx BCBL1 cells irrespective of
whether they had been induced with TPA+DOX. This demon-
strates that hyperphosphorylated 4E-BP1 is ejected from eIF4E
upon induction of the KSHV productive growth cycle in a
naturally infected PEL-derived B-cell line. Our failure to detect a
reduction in 4E-BP1 bound to 7-M GTP Sepharose following
reactivation-induced eIF4F assembly likely reflects i) the overall
abundance of 4E-BP1 combined with the non-linear chemilumi-
nescent detection methodology; and ii) at least 20% of cells within
the population that do not undergo lytic reactivation and maintain
the latent gene expression program.
Despite an increase in eIF4G binding to eIF4E upon induction
of lytic reactivation, a corresponding increase in PABP, an eIF4G-
associated protein, was not observed (Fig. 4A). Analysis of PABP
subcellular distribution in TREx BCBL1-RTA cells revealed that
PABP is predominately cytoplasmic in latently-infected cells.
However, TPA+DOX-induced reactivation redistributed PABP
Figure 3. Phosphorylation of the translational repressor 4E-BP1 in response to KSHV lytic reactivation. A. Activation of the PI3-Kinase
(PI3K) /AKT/TSC pathway by diverse stimuli results in phosphorylation and subsequent inactivation of 4E-BP1 by mTORC1. Hyperphosphorylated 4E-
BP1 releases the cap-binding protein eIF4E (shown bound to the mRNA 59 cap), making it available to bind eIF4G and assemble a functional eIF4F
complex composed of eIF4E, eIF4G, and eIF4A. The macrolide rapamycin inhibits mTORC1 and prevents 4E-BP1 phosphorylation. B.
Hyperphosphorylated 4E-BP1 accumulates following KSHV reactivation. TREx BCBL1 or TREx BCBL1-RTA cells were untreated (2) or treated (+)
with TPA+DOX in the presence or absence of rapamycin (Rap). At 48 h post-induction, total protein was harvested, fractioned by SDS-PAGE in a
17.5% gel and analyzed by immunoblotting using anti-4E-BP1. Arrowheads indicate the differential electrophoretic migration of the hypo- and hyper-
phosphorylated 4E-BP1 forms. C. Inhibition of 4E-BP1 phosphorylation does not affect KSHV reactivation. Top panel: TREx BCBL-1 cells were induced
with TPA+DOX in the presence and absence of rapamycin (rap). The fraction of ORF59 positive cells was quantified as described in the legend to
Fig. 1. Bottom panel: Total protein was isolated, fractionated by SDS-PAGE and analyzed by immunoblotting using the indicated antisera. RhoGDI:
loading control.
doi:10.1371/journal.ppat.1000334.g003
Translational Control during KSHV Reactivation
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polymerase processivity factor (Fig. 4E left panel; [27]). Remark-
ably, PABP appeared concentrated within DAPI-staining nuclei in
cells induced to reactivate (Fig. 4E right panel). Thus, while the
amount of PABP detected in association with eIF4F remained
constant in cells induced to reactivate, it is possible that PABP
Figure 4. Lytic reactivation of KSHV promotes eIF4F assembly. A. KSHV lytic reactivation increases the incorporation of eIF4E into the eIF4F
complex. Non-ionic detergent lysates (INPUT) prepared from TREx BCBL1 or TREx BCBL1-RTA cells either untreated (2) or treated (+) with TPA+DOX
for 48 h prior to harvesting were incubated with 7-methyl-GTP (7-M GTP) sepharose. The 7-M GTP cap-bound proteins (CAP) were fractionated by
SDS-PAGE and analyzed by immunoblotting using the indicated antisera. B. The abundance of eIF4F-core and associated components remains
constant in TREx BCBL1-RTA cells induced to reactivate. Total protein isolated from TREx BCBL1-RTA cells untreated (2) or treated (+) with TPA+DOX
for the indicated times was fractionated by SDS-PAGE and analyzed by immunoblotting for the indicated proteins. The asterisk indicates the slower-
migrating fully-glycosylated, mature form of K8.1. RhoGDI and actin: loading controls. C. TREx BCBL1-RTA cells contain relatively high levels of eIF4F
core and associated proteins. Total protein isolated from equal numbers of live, untreated TREx BCBL1-RTA or primary NHDF cells (1.5610
6/ml) was
fractionated by SDS-PAGE and analyzed by immunoblotting using the indicated antisera. D. Enrichment of 4E-BP1 hyperphosphorylated isoforms in
the 7-M GTP sepharose unbound fraction upon lytic reactivation. As in A except the 7-M GTP sepharose unbound, flow-through fraction (FLOW) was
fractionated by SDS-PAGE in 17.5% gels to resolve phosphorylated 4E-BP1 isoforms (hyper- vs. hypophosphorylated indicated by arrowheads) and
analyzed by immunoblotting using anti-4E-BP1 antisera. E. PABP redistribution during KSHV lytic reactivation. Left panel: At 48 h post-induction, TREx
BCBL1-RTA cells treated as described in A were collected, and immunostained using antisera specific for ORF59 (green signal) or PABP (red signal).
Images were viewed with Zeiss LSM510 Meta confocal microscope, and colocalization was evaluated. Right panel: Cells were processed and
immunostained for ORF59 and PABP as indicated for the left panel, but additionally counterstained with DAPI and viewed with a Zeiss Axiovert
fluorescence microscope. For better contrast, single-stain images are shown in black & white. The Rightmost panel is a merged image showing ORF59
(green), PABP (red), and DAPI (blue).
doi:10.1371/journal.ppat.1000334.g004
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and its recruitment to eIF4F complexes, thus contributing to the
global changes in the protein synthesis profile observed upon
reactivation.
Accumulation of phosphorylated eIF4E in latently-
infected PEL cells induced to reactivate
As a consequence of eIF4F assembly, eIF4G-associated
polypeptides, including the eIF4E-kinase Mnk1, are tethered to
the 59 mRNA terminus by eIF4E. To investigate the impact of
lytic reactivation on eIF4E phosphorylation, cytosolic lysates from
TREx BCBL1-RTA or TREx BCBL1 cells treated with
TPA+DOX for various times were fractionated by isoelectric
focusing (IEF) to resolve the phosphorylated and unphosphory-
lated isoforms. The relative abundance of phosphorylated vs
unphosphorylated eIF4E was then evaluated by immunoblotting
using anti-eIF4E antiserum. Phosphorylated eIF4E accumulates
over a 72 h period following the induction of reactivation in TREx
BCBL1-RTA cells as the relative ratio of phosphorylated to
unphosphorylated eIF4E increases (Fig. 5A) while the total steady-
state eIF4E level remains relatively unchanged (Fig. 4B). TPA+-
DOX treatment of the parental TREx BCBL1 line did not result
in a detectable increase in phosphorylated eIF4E. Together, these
results establish that reactivation of latent KSHV genomes in PEL
cells promotes the accumulation of phosphorylated eIF4E, and
suggest that either a virus-encoded or virus-induced gene product
plays a critical role in this process.
Phosphorylation of eIF4E involves eIF4F assembly, which
brings together the kinase, Mnk1, and its substrate, the cap-
binding protein eIF4E, both of which associate with eIF4G
[28,29]. In addition, Mnk1 must be activated by upstream
signaling components responsive to multiple biological stimuli or
stresses including the mitogen-activated protein kinases (MAPKs)
extracellular regulated kinase (ERK) and / or p38 (Fig. 5B) [30–
32]. To evaluate MAPKs activation during KSHV lytic
reactivation, lysates from TREx BCBL1 or TREx BCBL1-RTA
cells treated with TPA, DOX or a combination of both, were
fractionated by SDS-PAGE and analyzed by immunoblotting.
Greater levels of phospho-ERK were observed in TREx BCBL1
and TREx BCBL1-RTA cells after treatment with TPA+DOX or
TPA alone (Fig. 5C, lanes 1,2,5 and 6) in agreement with other
reports [33,34]. To distinguish between TPA-mediated and
KSHV-mediated ERK activation, TREx BCBL1 and TREx
BCBL1-RTA cells were treated with DOX alone prior to
evaluating ERK activation. Figure 5C demonstrates that DOX-
induced RTA expression in TREx BCBL1-RTA (lane 3) was
sufficient to increase phospho- ERK levels compared to untreated
cells (lane 4), without a discernible impact on total ERK levels
(Fig. 5C, lane 3 and 4). In contrast, DOX-treatment of TREx
BCBL1 cells did not activate ERK detectably (Fig. 5C, lanes 7 and
8). Together, these observations strongly suggest that induction of
RTA expression in PEL cells latently infected with KSHV triggers
ERK activation. Unlike ERK, phosphorylated p38 is detected in
latently-infected cells and its levels do not vary significantly after
lytic cycle induction (Fig. 5D). Thus, induction of RTA expression
and subsequent KSHV reactivation from latency in TREx BCBL1
cells promotes ERK phosphorylation without significantly altering
p38 activation. This demonstrates that two kinases required for
Figure 5. Phosphorylated eIF4E accumulates following KSHV lytic reactivation. A. KSHV reactivation stimulates eIF4E phosphorylation.
TREx BCBL1 or TREx BCBL1-RTA cells either untreated (2) or treated (+) with TPA+DOX were collected at the indicated times post-induction. Cytosolic
lysates were fractionated by IEF and analyzed by immunoblotting using anti-eIF4E. The arrowheads indicate the different mobilities of the phospho-
vs unphosphorylated eIF4E forms [respectively denoted as 4E–P and 4E]. B. Activation of the eIF4G-bound kinase Mnk1 by ERK and p38 in response to
diverse stimuli. Active Mnk1 phosphorylates eIF4E when both kinase (Mnk1) and substrate (eIF4E) are bound to eIF4G. C. KSHV lytic reactivation
activates ERK. TREx BCBL1 or TREx BCBL1-RTA cells were treated with TPA, DOX or TPA+DOX for 48 h. Total protein was subsequently isolated,
fractionated by SDS-PAGE and analyzed by immunoblotting using antibodies specific for RTA or ERK [phospho (denoted as ERK P) vs. total ERK].
RhoGDI: loading control. D. p38 is activated in latently-infected cells, and remains active upon KSHV lytic reactivation. Same as in B, except the
antisera was specific for phospho- (denoted as p38 P) or total p38.
doi:10.1371/journal.ppat.1000334.g005
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however, only ERK activation is directly RTA-responsive and
correlates with entry into the viral lytic program.
Post-transcriptional control of the viral lytic activator RTA
by the cellular eIF4E-kinase Mnk1
While not required for normal cell growth and development
[35], Mnk1 contributes to proper translational control and is
required for wild-type levels of viral replication in acutely infected
cells [7,36,37]. Involvement of Mnk1 activity in viral reactivation
from latency has not been reported. To determine if Mnk1 activity
contributes to KSHV reactivation from latency, accumulation of
lytic replication markers was measured in TREx BCBL1-RTA
cultures induced to reactivate in the presence and absence of the
small-molecule Mnk1-inhibitor CGP57380. Total lysates from
cells induced in the presence of CGP57380 were fractionated by
IEF or SDS-PAGE followed by immunoblotting to evaluate the
effectiveness of the Mnk1-inhibitor in this system. Figure 6A
clearly shows that phosphorylated eIF4E was not detected in
CGP57380-treated cultures under these conditions. Inhibiting
Mnk1 activity during KSHV reactivation impaired viral entry into
the lytic cycle as assessed by ORF59 immunostaining and
significantly reduced the overall abundance of the viral trans-
activator RTA along with the late glycoprotein K8.1 (Fig. 6B).
Furthermore, the reduced RTA polypeptide abundance in
CGP57380-treated cultures was not accompanied by a detectable
decrease in the corresponding steady-state mRNA levels as
measured by RT-PCR (Fig. 6C,D). These experiments demon-
strate that KSHV reactivation is impaired by inhibiting the
cellular eIF4E kinase Mnk1, and suggest that Mnk1 regulates the
accumulation of RTA, an essential master regulator of KSHV lytic
reactivation, via a post-transcriptional mechanism.
Discussion
Reactivation of latent herpesvirus infections in response to
environmental signals requires the abrupt implementation of a
new developmental gene expression program. While the onset of
this new program typically begins with a burst of new viral gene
transcription, proper control of cellular translational regulatory
pathways is likely to be critical for its execution. PEL-derived B-
cells naturally infected with KSHV provide a valuable model
system to study herpesvirus reactivation from latency [38].
However, up until now, it has not been possible to determine
how host translational control pathways contribute to or respond
to herpesvirus reactivation because of the limited efficiency with
which PEL-cells naturally infected with KSHV can be induced to
reactivate. By establishing conditions that promote high-level
reactivation of latent KSHV from PEL-cells, we demonstrate that
reactivation profoundly changes the ongoing protein synthesis
program in these cells. Inactivation of the translational repressor
4E-BP1, PABP nuclear accumulation, eIF4F assembly, and
phosphorylation of the cap-binding protein eIF4E by the cellular
eIF4G-asociated kinase Mnk1 occur in parallel with alterations to
the protein synthesis profile. Inhibiting Mnk1 reduces accumula-
tion of the critical viral transactivator RTA through a post-
transcriptional regulatory mechanism, limits the production of
downstream lytic proteins, and impairs the overall efficiency of
viral reactivation.
The latent-lytic replication switch triggers substantial changes in
the ongoing protein synthesis profile. PABP redistribution from the
cytoplasm to the nucleus in response to lytic reactivation could
contribute to this. The KSHV-encoded vIRF4 (K10/10.1)
polypeptide expressed during the lytic cycle reportedly associates
with PABP and might mediate these effects either alone or in
conjunction with other viral factors [39]. A different tactic to
rapidly switch the profile of newly synthesized proteins in
reactivating cells might involve SOX, the KSHV ORF37 gene
product shown to impair protein synthesis in immortalized
endothelial cells by accelerating global mRNA turnover [25].
Faster host and viral mRNA-turnover appears to be a common
strategy used by different viruses to comprehensively impair
Figure 6. Regulation of RTA abundance by the eIF4E-kinase
Mnk1. A. Mnk-inhibitors prevent eIF4E phosphorylation during lytic
reactivation of PEL-cells. TREx BCBL1-RTA cells were induced with
TPA+DOX in presence (+) or absence (2) of the Mnk inhibitor CGP57380
(20 nM). After 48 h, total protein was isolated, fractionated by IEF and
analyzed by immunoblottting as described in the Fig. 5 legend. B.
Suppression of KSHV reactivation by Mnk-inhibitors. Top panel: TREx
BCBL1-RTA cells were treated as described in A. The fraction of ORF59-
positive cells was quantified as described in the legend to Fig. 1.
Bottom panel: Lysates from cells treated as in A were fractionated by
SDS-PAGE and analyzed by immunoblotting using the indicated
antisera. RhoGDI: loading control. C. Treatment with CGP57380 does
not affect ORF50 (RTA) mRNA levels. Total RNA was extracted from cells
treated as described in panel A and reverse transcription performed on
250 ng of total RNA from each sample. PCR reactions were then
performed on 1% of the resulting cDNAs using specific primers for
ORF50 (RTA) or 28S rRNA. ORF50 transcripts originating from the viral
genomic locus and the DOX-regulated cDNA generate identical
amplification products, the latter being the more abundant. Samples
were quantified by gel densitometry. Error bars: Standard deviations
from independent triplicate experiments. D. Mnk-inhibitors reduce RTA
protein accumulation in response to a reactivation signal. Total protein
lysates from cells treated as described in C were fractionated by SDS-
PAGE and analyzed by immunoblotting using the indicated antisera.
Samples were quantified by gel densitometry. Error bars: Standard
deviations from independent triplicate experiments.
doi:10.1371/journal.ppat.1000334.g006
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transition between different temporal classes of viral transcripts
[43,44]. Under these conditions, viral mRNA translation is
maintained and appears selective simply because viral gene
transcription proceeds at a high level, continually replenishing
the mRNA pool compared to the bulk of host mRNAs [45].
Significantly, certain host mRNAs escape this restriction and can
be translated, potentially contributing to or antagonizing viral
replication [41]. Finally, all herpesvirus family members encode a
post-transcriptional regulator essential for lytic replication that
represses export of host intron-containing mRNAs, but shuttles
between the nucleus and cytoplasm to promote export of viral
mRNAs, the vast majority of which lack introns [46–49]. Thus,
changes to the protein synthesis profile resulting from lytic
reactivation are likely achieved through the synergistic action of
multiple, independent viral functions.
While reactivation dramatically impairs overall ongoing protein
synthesis, we now establish that multiple aspects of the host
translation machinery are activated rather than inhibited. From
the virus standpoint, this makes sense because the translation
apparatus must engage viral mRNAs to execute the lytic
developmental program. Whereas modification of translation
initiation factors required for cap-dependent mRNA translation
occurs in cells acutely infected with related alpha (HSV-1) or beta
(HCMV) herpesviruses [7,26,37], or poxviruses (vaccinia) [36],
this is the first demonstration that reactivation from latency
activates the host translation machinery.
Normally, hyperphosphorylation of the 4E-BP1 translational
repressor by mTORC1 releases the cap-binding protein eIF4E,
allowing eIF4E to associate with eIF4G and assemble the eIF4F
complex. Unexpectedly, while KSHV lytic reactivation stimulated
the rapamycin-sensitive kinase mTORC1, 4E-BP1 hyperpho-
sphorylation and eIF4F assembly, complete 4E-BP1 ejection from
eIF4E was not observed. While the 4E-BP1 fraction released from
eIF4E was enriched in hyperphosphorylated isoforms, the
remaining eIF4E-bound fraction is likely hyphosphorylated.
Despite the relatively high efficiency with which our conditions
promote reactivation, lytic gene expression was not detected
routinely in at least 20% of the cells. Given the high levels of
eIF4E, eIF4G and 4E-BP1 in uninduced TREx BCBL1-RTA
cells, the fraction of hypophosphorylated 4E-BP1 retained by
eIF4E is likely derived from the sub-population of cells that have
not initiated lytic reactivation. Elevated 4E-BP1 levels in cancer
cells are not incompatible with ongoing translation, and in fact
promote the translation of select mRNAs involved in angiogenesis
and cell growth [50]. We cannot, however, exclude that 4E-BP1
inactivation is incomplete in cells induced to reactivate, and this
might foster a balance between cap-dependent and cap-indepen-
dent translation of select host and viral mRNAs. Regardless of
which of these alternatives proves correct, we have shown that the
repressor 4E-BP1 is stably bound to eIF4E in these latently-
infected cells, and viral reactivation results in its partial release
with an accompanying eIF4G-recruitment into an eIF4E-contain-
ing complex. Furthermore, rapamycin blocked 4E-BP1 phosphor-
ylation without detectably reducing lytic reactivation. eIF4E levels
in excess of 4E-BP1 could allow for ongoing cap-dependent
translation in these cells. The absence of detectable hyperpho-
sphorylated 4E-BP1 and p70S6K (unpub. obs.) in latently-infected
TREx BCBL1 and TREx BCBL1-RTA cell lines raises questions
as to the involvement of mTORC1 on their proliferation in
culture. Rapamycin reportedly inhibits proliferation of KSHV-
positive PEL-lines [51,52] and the KSHV-encoded vGPCR G-
protein coupled receptor is implicated in endothelial cell
transformation by inactivating the tuberous-sclerosis complex
(TSC), an upstream negative-regulator of mTORC1 [53].
Paradoxically, vGPCR expression in PEL-lines causes G1 arrest,
consistent with observations made during the herpesvirus lytic
replication cycle, but incompatible with a potential role as an
oncogene driving proliferation of latently-infected PEL cells [54].
vGPCR transcripts are expressed as an early lytic mRNA in PEL-
cell lines, but low levels are also detected in PEL clinical samples
[55]. Whether the signal detected was derived from the truly latent
component of the population or a fraction undergoing spontane-
ous reactivation has not been established. Notwithstanding
numerous differences between endothelial and B-cells, our work
supports the notion that a virus-encoded function such as vGPCR
activates mTORC1 and stimulates 4E-BP1 hyperphosphorylation
upon induction of KSHV lytic reactivation. This contrasts with
proliferating B-cell lines latently infected with the related c-
herpesvirus EBV, where the latency protein LMP-2 activates PI3-
kinase /Akt, resulting in 4E-BP1 hyperphosphorylation by
mTORC1 [56].
In addition to inactivating the repressor 4E-BP1 through
mTORC1, KSHV reactivation activates ERK 1/2 MAP-kinase
and its downstream target Mnk1, the cellular eIF4G-associated,
eIF4E-kinase. In cells acutely infected with poxviruses or related
herpesvirus family members HSV-1 and HCMV, Mnk1-mediated
eIF4E phosphorylation enhances viral protein accumulation, viral
replication and spread [7,36,37]. In addition, eIF4E overexpres-
sion can contribute to malignant transformation [57], and more
recently, eIF4E phosphorylation has been implicated in tumori-
genesis [58]. Here, we now establish that inhibiting Mnk1 prevents
eIF4E phosphorylation and reduces KSHV reactivation from
latency. Moreover, we demonstrate that Mnk1 activity post-
transcriptionally regulates Rta abundance. Increased phosphory-
lated eIF4E abundance mediated by Mnk1 activity likely reflects
eIF4F complex assembly on the newly transcribed Rta 59 mRNA
terminus, as eIF4E phosphorylation occurs following eIF4F
assembly when both the kinase Mnk1 and its substrate, eIF4E,
are bound to eIF4G [26]. While Mnk1 and eIF4E phosphorylation
are not essential for translation, they might impart a level of
control that governs the efficiency with which translation initiates
on newly minted or derepressed mRNAs. Should this hypothesis
prove true, contributions by Mnk1 and / or eIF4E phosphory-
lation to the efficiency with which newly transcribed or
derepressed mRNAs are translated is likely not to be confined to
viral biology, but may also be incorporated into a repertoire of




TREx BCBL1 and TREx BCBL1-RTA (kindly provided by Dr.
Jae Jung, USC, Los Angeles, CA) were maintained in DMEM
supplemented with 20% Fetalplex (Gemini), L-glutamine
(200 mM, Invitrogen), penicillin (100 U/ml, Gibco) and strepto-
mycin (100 mg/ml, Gibco). TRExBCBL1-RTA cells were grown
in presence of hygromycin B (100 mg/ml) to maintain selection for
the ORF50 (RTA) gene.
The following antibodies were purchased from commercial
suppliers: Cell Signaling Technologies [anti-p38 (Cat. 9212),
phospho-p38 (Cat. 9216S), p41/p42 ERK (Cat. 9102), phospho-
ERK (Cat. 9101S)]; Bethyl Labs [anti-4EBP1 (Cat. A300-501A)];
BD Transduction labs [anti-eIF4E (Cat. 610269)]; Santa Cruz
Biotechnology [anti-RhoGDI (Cat. SC-360)]; Adv. Biotechnolo-
gies Inc. [anti-KSHV K8.1 (Cat. 13-212-100)]. The following
antibodies were generous gifts: anti-ORF59, Dr. Bala Chandran
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monoclonal, Dr. Robert Schneider (NYU School of Medicine,
New York, NY); anti-RTA, Dr. Gary Hayward (Johns Hopkins
School of Medicine, Baltimore, MD).
Induction of KSHV lytic replication in PEL-derived cells
TREx BCBL1 and TREx BCBL1-RTA cells were seeded at
1.5610
5 cells/ml. 24 h after seeding, cells were induced with 2-O-
tetradecanoylphorbol-13-acetate (TPA 20 ng/ml, Cat. P1585,
Sigma), doxycycline (2 mg/ml, Cat. 631311, BD Bioscience) or
both TPA+DOX. Where indicated, cells were pretreated for 1 h
with CGP57380 (20 mM, Cat. 454861 Calbiochem) or rapamycin
(100 nM, Cat. 553210 Calbiochem), followed by induction in
presence of these drugs. At the indicated times after induction,
3610
5 live cells were collected, resuspended in 125 ml of SDS lysis
buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.7 M
b–mercaptoethanol) and boiled for 3 min.
Immunofluorescence analysis
TREx BCBL1 or TREx BCBL1-RTA cells were attached to
poly-L-lysine-treated (0.1% for 1 h) coverslips. Cells were fixed in
3.7% formaldehyde, permeabilized with 0.1% Triton-X100+RN-
ase A (100 mg/ml), blocked with PBS-B [PBS+10% FBS+0.25%
saponin], and subsequently incubated with primary antibody
diluted in PBS-B for 1 h at 37uC. Cells were washed and probed
with secondary antibody diluted in PBS-B for 1 h at 37uC. DNA
was stained with propidium iodide or DAPI. Coverslips were
mounted onto glass slides with Dako, and fluorescent images
collected with a Carl Zeiss LSM510 Meta confocal laser-scanning
microscope or a Zeiss Axiovert fluorescence microscope, using
metamorph software.
Analysis of protein synthesis in TREx BCBL1 and TREx
BCBL1-RTA cells
At the indicated times post-induction, 6610
5 live TREx BCBL1
or TREx BCBL1-RTA cells were incubated for 30 min with
7 mCi/ml of
35S Express (Perkin Elmer) in serum-free DMEM
lacking methionine+cysteine. Cells were collected, lysed in 250 ml
of SDS lysis buffer and the samples boiled for 3 min. An aliquot of
the cell lysate was fractionated by SDS-PAGE in a 12.5%
polyacrylamide gel. The gel was fixed, dried and exposed to X-
OMAT X-ray film overnight.
Immunoblotting , isoelectric focusing and 7-Methyl GTP
chromatography
Immunoblotting and isoelectric focusing (IEF) were performed
as previously described [7]. Isolation of eIF4E-bound proteins by
7-Methyl GTP batch chromatography was essentially performed
as previously reported [37] in lysates from 1.5610
6 live TREx-
BCBL-1 or TREx-BCBL-1/RTA cells 48 h post-induction with
TPA+DOX.
Semi-quantitative and real-time RT-PCR
Total RNA was extracted from 1610
6 TREx BCBL1-RTA cells
induced for 48 h with TPA+DOX in the presence or absence of
20 nM CGP57380 using Trizol reagent (Invitrogen). Reverse
transcription was performed on 250 ng of each RNA with
SuperScript First-Strand Synthesis System (Invitrogen) and 1%
of the cDNA product was used for PCR amplification. Products
were separated on a 2% agarose gel and quantified by scanning
densitometry. Spliced ORF50 (RTA) transcripts were detected
using primers [59] located in the 59 UTR (59-CA-
CAAAAATGGCGCAAGATGA-39) and second exon (59-
TGGTAGAGTTGGGCCTTCAGTT-39). These primers do
not distinguish between transcripts derived from the viral genomic
locus and the Dox-regulated cDNA present in TREx BCBL1-Rta
cells. 28S RNA served as a normalization control and was
amplified using the following primers: 59-AAACTCTGGTG-
GAGGTCCGT-39,5 9-CTTACCAAAAGTGGCCCACTA-39.
Changes in the abundance of representative cellular mRNAs in
DMSO-treated or TPA+DOX-induced cells was measured by
real-time RT-PCR analysis using a Lightcycler 2.0 (Roche Applied
Science) and the following primer pairs: b-actin 59-
GCGGGAAATCGTCGGTGACATT-39,5 9-GATGGAGTT-
GAAGGTAGTTTCGTG-39; glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) 59-CCTCAACGACCACTTTGTCA-39,5 9-
CCCTGTTGCTGTAGCCAAAT-39; interleukin-2 (IL-2) 59-
CCCAGGGACTTAATCAGCAA-39,5 9-GGTTGCTGTCTCA-
TCAGCAT-39; and b-catenin 59-CCCACTGGCCTCTGA-
TAAAGG-39,5 9-ACGCAAAGGTGCATGATTTG-39. Samples
were normalized using 28S RNA.
Supporting Information
Figure S1 TPA+DOX treatment of TREx BCBL1-RTA cells
results in the production of infectious KSHV particles. A. Using a
luciferase reporter cell line to detect infectious KSHV produced by
TREx BCBL1-RTA cultures in the presence and absence of
inducer. Asynchronous cultures of TREx BCBL1-RTA cells
(150 ml total seeded at 2610
5 cells /ml) were induced with
TPA+DOX or mock-induced using DMSO as described. After 6
days, a cell-free lysate was prepared by freeze-thawing and cell
debris was removed by centrifugation (8006g for 10 min at 4uC).
After passage through a 0.8 m filter, the supernatant was floated on
top of a 7 ml cushion of 50 mM Tris-HCl, pH 7.2, 1 mM MgCl2,
20% sorbitol and centrifuged at 20,000 rpm for 90 min in a SW28
rotor at room temperature. The viral pellet was resuspended in
0.5 ml DMEM+1.5% fraction V BSA and 0.125 ml was applied
to approximately 1.5–3610
5 293 PAN-luc reporter cells. After
48 h, the cells were harvested and the luciferase activity present in
a fraction of the sample was measured (shown in B) using
commercially available reagents (Promega).
Found at: doi:10.1371/journal.ppat.1000334.s001 (1.01 MB TIF)
Acknowledgments
We are grateful to Jae Jung for providing TREx BCBL1 lines; Bala
Chandran, Simon Morley, and Bob Schneider for generous antisera gifts;
Preet Chaudhary for the 293 PAN-luc reporter cells; and Alexandre Blais,
Diego Acosta-Alvear, and our colleagues in the Wilson & Mohr labs for
many insightful discussions. In particular, we thank Linda Persson for
assistance with the virus yield assays and Søren Ottosen for his imaging
expertise.
Author Contributions
Conceived and designed the experiments: CA DW ACW IM. Performed
the experiments: CA DW JH. Analyzed the data: CA DW JH ACW IM.
Wrote the paper: CA DW ACW IM.
References
1. Ron D, Harding HP (2007) eIF2a phosphorylation in cellular stress responses
and disease. In: Mathews MB, Sonenberg N, Hershey JWB, eds. Translational
control in biology and medicine. Cold Spring Harbor: Cold Spring Harbor
Laboratory Press. pp 345–368.
Translational Control during KSHV Reactivation
PLoS Pathogens | www.plospathogens.org 10 March 2009 | Volume 5 | Issue 3 | e10003342. Thompson B, Wickens M, Kimble J (2007) Translational control in
development. In: Mathews MB, Sonenberg N, Hershey JWB, eds. Translational
control in biology and medicine. Cold Spring Harbor: Cold Spring Harbor
Laboratory Press. pp 507–544.
3. Raught B, Gingras AC (2007) Signaling to translation initiation. In:
Mathews MB, Sonenberg N, Hershey JWB, eds. Translational control in
biology and medicine. Cold Spring Harbor: Cold Spring Harbor Laboratory
Press. pp 369–400.
4. Morley SJ, Rau M, Kay JE, Pain VM (1993) Increased phosphorylation of
eukaryotic initiation factor 4 {alpha} during activation of T lymphocytes
correlates with increased eIF-4F complex formation. Eur J Biochem 218: 39–48.
5. Beretta L, Singer NG, Hinderer R, Gingras AC, Richardson B, et al. (1998)
Differential regulation of translation and eIF4E phosphorylation during human
thymocyte maturation. J Immunol 160: 3269–3273.
6. Dyer JR, Michel S, Lee W, Catellucci VF, Wayne NL, et al. (2003) An activity-
dependent switch to cap-independent translation triggered by eIF4E dephos-
phorylation. Nat Neurosci 6: 219–220.
7. Walsh D, Mohr I (2004) Phosphorylation of eIF4E by Mnk-1 enhances HSV-1
translation and replication in quiescent cells. Genes Dev 18: 660–672.
8. Oppenheim AB, Kobiler O, Stavans J, Court DL, Adhya S (2005) Switches in
bacteriophage lambda development. Annu Rev Genet 39: 409–429.
9. Ganem D (2007) Kaposi’s Sarcoma-Associated Herpesvirus. In: Knipe DM,
Howley PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins.
10. Paulose-Murphy M, Ha NK, Xiang C, Chen Y, Gillim L, et al. (2001)
Transcription program of human herpesvirus 8 (kaposi’s sarcoma-associated
herpesvirus). J Virol 75: 4843–4853.
11. Jenner RG, Alba ` MM, Boshoff C, Kellam P (2001) Kaposi’s sarcoma-associated
herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol
75: 891–902.
12. Bartkoski M, Roizman B (1976) RNA synthesis in cells infected with herpes
simple virus. XIII. Differences in the methylation patterns of viral RNA during
the reproductive cycle. J Virol 20: 583–588.
13. Sun R, Lin SF, Gradoville L, Miller G (1996) Polyadenylylated nuclear RNA
encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 93:
11883–11888.
14. Zhong W, Ganem D (1997) Characterization of ribonucleoprotein complexes
containing an abundant polyadenylated nuclear RNA encoded by Kaposi’s
sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 71: 1207–1212.
15. Gu M, Lima CD (2005) Processing the message: structural insights into capping
and decapping mRNA. Curr Opin Struct Biol 15: 99–106.
16. Bentley DL (2005) Rules of engagement: co-transcriptional recruitment of pre-
mRNA processing factors. Curr Opin Cell Biol 17: 251–256.
17. Mohr I, Pe’ery T, Mathews MB (2007) Protein synthesis and translational
control during viral infection. In: Mathews MB, Sonenberg N, Hershey JWB,
eds. Translational control in biology and medicine. Cold Spring Harbor: Cold
Spring Harbor Laboratory Press. pp 545–595.
18. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, et al. (1998) A viral gene that
activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus. Proc
Natl Acad Sci USA 95: 10866–10871.
19. Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, et al. (2000) Kaposi’s
sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the
entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J Virol
74: 6207–6212.
20. Lukac DM, Renne R, Kirshner JR, Ganem D (1998) Reactivation of Kaposi’s
sarcoma-associated herpesvirus infection from latency by expression of the ORF
50 transactivator, a homolog of the EBV R protein. Virology 252: 304–312.
21. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, et al. (2003) Global
changes in Kaposi’s sarcoma-associated virus gene expression patterns following
expression of a tetracycline-inducible Rta transactivator. J Virol 77: 4205–4220.
22. Deng H, Young A, Sun R (2000) Auto-activation of the RTA gene of human
herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus. J Gen Virol 81:
3043–3048.
23. Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, et al. (2007) K13 blocks
KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of
lytic replication induced clonal selection in viral oncogenesis. PLoS ONE 2:
e1067. doi:10.1371/journal.pone.0001067.
24. Inoue N, Winter J, Lal RB, Offermann MK, Koyano S (2003) Characterization
of entry mechanisms of human herpesvirus 8 by using an Rta-dependent
reporter cell line. J Virol 77: 8147–8152.
25. Glaunsinger B, Ganem D (2004) Lytic KSHV infection inhibits host gene
expression by accelerating global mRNA turnover. Mol Cell 13: 713–723.
26. Walsh D, Mohr I (2006) Assembly of an active translation initiation factor
complex by a viral protein. Genes Dev 20: 461–472.
27. Chan SR, Chandran B (2000) Characterization of human herpesvirus 8 ORF59
protein (PF-8) and mapping of the processivity and viral DNA polymerase-
interacting domains. J Virol 74: 10920–10929.
28. Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T, et al. (1999)
Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to
phosphorylate eIF4E. EMBO J 18: 270–279.
29. Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR, et al. (1999)
Phosphorylation of the cap-binding protein eukaryotic translation initiation
factor 4E by protein kinase Mnk1 in vivo. Mol Cell Biol 19: 1871–1880.
30. Fukunaga R, Hunter T (1997) MNK1, a new MAP kinase-activated protein
kinase, isolated by a novel expression screening method for identifying protein
kinase substrates. EMBO J 16: 1921–1933.
31. Wang X, Flynn A, Waskiewicz AJ, Webb BL, Vries RG, et al. (1998) The
phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol
esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways.
J Biol Chem 273: 9373–9377.
32. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA (1997) Mitogen-activated
protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J
16: 1909–1920.
33. Cohen A, Brodie C, Sarid R (2006) An essential role of ERK signalling in TPA-
induced reactivation of Kaposi’s sarcoma-associated herpesvirus. J Gen Virol 87:
795–802.
34. Ford PW, Bryan BA, Dyson OF, Weidner DA, Chintalgattu V, et al. (2006)
Raf/MEK/ERK signalling triggers reactivation of Kaposi’s sarcoma-associated
herpesvirus latency. J Gen Virol 87: 1139–1144.
35. Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R (2004)
Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of
eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell
Biol 24: 6539–6549.
36. Walsh D, Arias C, Perez C, Halladin D, Escandon M, et al. (2008) Eukaryotic
translation initiation factor 4F architectural alterations accompany translation
initiation factor redistribution in poxvirus-infected cells. Mol Cell Biol 28:
2648–2658.
37. Walsh D, Perez C, Notary J, Mohr I (2005) Regulation of the translation
initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-
infected cells. J Virol 79: 8057–8064.
38. Deng H, Liang Y, Sun R (2007) Regulation of KSHV lytic gene expression.
Curr Topics in Micro and Imm 312: 157–183.
39. Kanno T, Sato Y, Sata T, Katano H (2006) Expression of Kaposi’s sarcoma-
associated herpesvirus-encoded K10/10.1 protein in tissues and its interaction
with poly(A)-binding protein. Virology 352: 100–109.
40. Rowe M, Glaunsinger B, van Leeuwen D, Zuo J, Sweetman D, et al. (2007) Host
shutoff during productive Epstein-Barr virus infection is mediated by BGLF5
and may contribute to immune evasion. Proc Natl Acad Sci USA 104:
3366–3371.
41. Glaunsinger BA, Ganem DE (2006) Messenger RNA turnover and its regulation
in herpesviral infection. Adv Virus Res 66: 337–394.
42. Parrish S, Moss B (2007) Characterization of a second vaccinia virus mRNA-
decapping enzyme conserved in poxviruses. J Virol 81: 12973–12978.
43. Oroskar AA, Read GS (1989) Control of mRNA stability by the virion host
shutoff function of herpes simplex virus. J Virol 63: 1897–1906.
44. Kwong AD, Frenkel N (1987) Herpes simplex virus-infected cells contain a
function(s) that destabilizes both host and viral mRNAs. Proc Natl Acad Sci
USA 84: 1926–1930.
45. Mohr I (2006) Hailing the arrival of the messenger: Strategies for translational
control in herpes simplex virus-infected cells. In: Sandri-Goldin RM, ed. Alpha
herpesviruses: Molecular and cellular biology. Norwich: Horizon Scientific
Press. pp 105–120.
46. Sandri-Goldin RM (2008) The many roles of the regulatory protein ICP27
during herpes simplex virus infection. Front in Biosci 13: 5241–5256.
47. Bello LJ, Davidson AJ, Glenn MA, Whitehouse A, Rethmeier N, et al. (1999)
The human herpesvirus-8 ORF57 gene and its properties. J Gen Virol 80:
3207–3215.
48. Boyne JR, Colgan KJ, Whitehouse A (2008) Herpesvirus saimiri ORF57: a post-
transcriptional regulatory protein. Front in Biosci 13: 2928–2938.
49. Kirshner JR, Lukac DM, Chang J, Ganem D (2000) Kaposi’s sarcoma-
associated herpesvirus open reading frame 57 encodes a posttranscriptional
regulator with multiple distinct activities. J Virol 74: 3586–3597.
50. Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, et al. (2007) A
hypoxia-controlled cap-dependent to cap-independent translation switch in
breast cancer. Mol Cell 28: 501–512.
51. Sin SH, Roy D, Wang L, Staudt MR, Fakhari FD, et al. (2007) Rapamycin is
efficacious against primary effusion lymphoma (PEL) cell lines in vivo by
inhibiting autocrine signaling. Blood 109: 2165–2173.
52. Dittmer DP, Krown SE (2007) Targeted therapy for Kaposi’s sarcoma and
Kaposi’s sarcoma-associated herpesvirus. Curr Opin Oncol 19: 452–457.
53. Sodhi A CR, Hu J, Ramsdell AK, Manning BD, Sausville EA, Sawai ET,
Molinolo A, Gutkind JS, Montaner S (2006) The TSC2/mTOR pathway drives
endothelial cell transformation induced by the Kaposi’s sarcoma-associated
herpesvirus G protein-coupled receptor. Cancer Cell 10: 133–143.
54. Cannon M, Cesarman E, Boshoff C (2006) KSHV G protein-coupled receptor
inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-
mediated inhibition of Cdk2. Blood 107: 277–284.
55. Nador RG, Milligan LL, Flore O, Wang X, Arvanitakis L, et al. (2001)
Expression of Kaposi’s sarcoma-associated herpesvirus G protein-coupled
receptor monocistronic and bicistronic transcripts in primary effusion lympho-
mas. Virology 287: 62–70.
56. Moody CA, Scott RS, Amirghahari N, Nathan CA, Young LS, et al. (2005)
Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded
LMP2A. J Virol 79: 5499–5506.
57. Schneider RJ, Sonenberg N (2007) Translational control in cancer development
and progression. In: Mathews MB, Sonenberg N, Hershey JWB, eds.
Translational Control during KSHV Reactivation
PLoS Pathogens | www.plospathogens.org 11 March 2009 | Volume 5 | Issue 3 | e1000334Translational control in biology and medicine. Cold Spring Harbor: Cold
Spring Harbor Laboratory Press. pp 401–431.
58. Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, et al. (2007) Dissecting
eIF4E action in tumorigenesis. Genes Dev 21: 3232–3237.
59. Fakhari FD, Dittmer DP (2002) Charting latency transcripts in Kaposi’s
sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR.
J Virol 76: 6213–6223.
Translational Control during KSHV Reactivation
PLoS Pathogens | www.plospathogens.org 12 March 2009 | Volume 5 | Issue 3 | e1000334